Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2023

Go back to Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2023
(NASDAQ: CNTA) Delayed: 40.18 --0 (-0%)
Previous Close $40.18    52 Week High
Open $40.18    52 Week Low
Day High $40.18    P/E N/A 
Day Low $40.18    EPS
Volume